5 Best New Tech Stocks to Buy Now

2. Bausch + Lomb Corporation (NYSE:BLCO)

Number of Hedge Fund Holders: 25    

Bausch + Lomb Corporation (NYSE:BLCO) operates as an eye health company worldwide. On October 24, Bausch + Lomb Corp revealed that it will launch the Project Watson line of health care products for dogs that is focused on eye and ear health. The products include an eye wash, eye chewable supplement, and ear wash and wipes. 

On November 3, H.C. Wainwright analyst Yi Chen maintained a Buy rating on Bausch + Lomb Corporation (NYSE:BLCO) stock and lowered the price target to $20 from $21, highlighting that the company missed the third quarter expectations. 

At the end of the third quarter of 2022, 25 hedge funds in the database of Insider Monkey held stakes worth $402.7 million in Bausch + Lomb Corporation (NYSE:BLCO), compared to 19 in the previous quarter worth $304.8 million.